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ABSTRACT 
Suphavilai, Chayaporn. M.S., Purdue University, May 2014. Computational Development 
of Regulatory Gene Set Networks for Systems Biology Applications. Major Professor: 
Jake Chen. 
 
 
 
In systems biology study, biological networks were used to gain insights into biological 
systems. While the traditional approach to studying biological networks is based on the 
identification of interactions among genes or the identification of a gene set ranking 
according to differentially expressed gene lists, little is known about interactions between 
higher order biological systems, a network of gene sets. Several types of gene set network 
have been proposed including co-membership, linkage, and co-enrichment human gene 
set networks. However, to our knowledge, none of them contains directionality 
information.  Therefore, in this study we proposed a method to construct a regulatory 
gene set network, a directed network, which reveals novel relationships among gene sets. 
A regulatory gene set network was constructed by using publicly available gene regulation 
data. A directed edge in regulatory gene set networks represents a regulatory relationship 
from one gene set to the other gene set. A regulatory gene set network was compared 
with another type of gene set network to show that the regulatory network provides 
additional information.  In order to show that a regulatory gene set network is useful for 
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understand the underlying mechanism of a disease, an Alzheimer's disease (AD) 
regulatory gene set network was constructed.  
In addition, we developed Pathway and Annotated Gene-set Electronic Repository 
(PAGER), an online systems biology tool for constructing and visualizing gene and gene 
set networks from multiple gene set collections. PAGER is available at 
http://discern.uits.iu.edu:8340/PAGER/. Global regulatory and global co-membership 
gene set networks were pre-computed. PAGER contains 166,489 gene sets, 92,108,741 
co-membership edges, 697,221,810 regulatory edges, 44,188 genes, 651,586 unique gene 
regulations, and 650,160 unique gene interactions. PAGER provided several unique 
features including constructing regulatory gene set networks, generating expanded gene 
set networks, and constructing gene networks within a gene set. 
However, tissue specific or disease specific information was not considered in the disease 
specific network constructing process, so it might not have high accuracy of presenting 
the high level relationship among gene sets in the disease context. Therefore, our 
framework can be improved by collecting higher resolution data, such as tissue specific 
and disease specific gene regulations and gene sets. In addition, experimental gene 
expression data can be applied to add more information to the gene set network. For the 
current version of PAGER, the size of gene and gene set networks are limited to 100 nodes 
due to browser memory constraint. Our future plans is integrating internal gene or 
proteins interactions inside pathways in order to support future systems biology study. 
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CHAPTER 1. INTRODUCTION 
1.1 Introduction 
Today a large amount of high throughput data from biological experiments has been 
produced. High-throughput sequencing and gene profiling techniques have transformed 
biological research by enabling comprehensive understanding of a biological system [26]. 
In consequence, many differentially expressed gene lists were generated for different 
kinds of experiments such as disease gene expression profile and drug sensitivity gene 
expression profile.  This situation presented a new challenge of extracting meaning from 
the long list of genes. The traditional approach to study biological network is based on 
identification of interaction among genes or proteins. However, several biological 
processes often coordinately function together and higher level relationships among 
biological processes have not been well studied yet. Therefore, networks of gene sets 
have been proposed in order to reveal the higher level relationships among gene sets 
where a gene set is a group of genes that belong to the same pathway, share common 
biological processes, or belong to the same disease. 
Pathway analysis is a method for gaining insight into the underlying biology of 
differentially expressed genes and proteins. It analyzes a list of differentially expressed 
genes and returns significant pathways, which highly relate to the gene list. A pathway
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can be considered as a gene set which contains all genes or proteins in the pathway. 
Therefore, in some scenarios, pathway analysis and gene set analysis are the same 
analysis. However, in some cases the analysis of pathway and the analysis of gene set can 
be different. For example, a biological pathway consists of a series of interactions among 
molecules, but a gene set is a set of genes which might not have information of 
interactions among its genes. In this case, if an analysis requires information of the 
interactions among molecules, the analysis might not appropriate to analyze gene sets. 
Typically, researchers use several techniques of pathway analysis to reveal a novel insight 
into their gene lists. Pathways or gene sets information were provided by several data 
sources such as Pathway Interaction Database (PID)[35] and MSigDB [28]. These 
experimental validated pathways or gene sets were used as a knowledge base. The first 
simple approach of pathway analysis is evaluating the number of genes from a 
differentially expressed gene list which are found in a particular pathway. The more 
advanced method is calculating the gene-level statistic for all genes in a pathway and 
aggregating the gene-level statistics into a single pathway-level statistic. In some studies, 
a pathway is considered as a gene set, which is a group of genes that share common 
biological function or regulation. For example, Gene set enrichment analysis (GSEA) [36] is 
a method to calculate gene set-level statistics. Researchers input their gene expression 
data from the experiment, GSEA then calculates gene-level statistics and use the gene-
level statistics to calculate an enrichment score for each gene set. In addition, using gene 
set-level statistics has an advantage because significant analysis at single gene level 
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suffers from a limited number of sample and noise [14].  Gene set based methods have 
also been developed to investigate phenotypic changes at the pathway level. For example, 
genetic perturbations have been implicated for initiation and progression of cancer and 
these perturbations are most likely reflected by the altered expression of sets of genes or 
pathways [11]. The next generation of pathway analysis also incorporates pathway 
topology and interaction of genes or proteins inside a pathway. By using both gene 
expression data and pathway topology, researchers obtain a better ranking of gene sets 
corresponding to their differentially expressed gene lists. 
In systems biology study, two levels of biological network, gene network and gene set 
network, were used to gain insights into biological systems. The traditional approach to 
studying complex biological networks is based on the identification of interactions among 
genes or the identification of gene set ranking according to differentially expressed gene 
lists. Little is known about interactions between higher order biological systems, a 
network of gene sets. Several studies proposed methods to construct gene set networks. 
Yong Li, et al. constructed a pathway crosstalk network and a linkage network in order to 
understand the relationship between pathways [27]. Dikla, et al. proposed a methodology 
for gleaning patterns of interactions between biological processes by analyzing protein-
protein interactions, transcriptional co-expressions and genetic interactions [10]. In 
addition, a gene set network can be used for understanding diseases. For example, Zhi-
Ping, et al. proposed a network-based systems biology approach to detect the crosstalks 
among AD related pathways and the dysfunctions in the six brain regions of AD patients 
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[29]. Kelder, et al. proposed an analysis approach to study interactions between pathways 
in a mouse by integrating gene and protein interaction networks, biological pathway 
information and high-throughput data [24]. 
Recently, Jignesh, et al. proposed methods to construct multi-edge gene set networks to 
reveal insights into global relationships between biological themes or gene sets [32]. The 
multi-edge network consists of three types of edges: co-membership, linkage, and co-
enrichment.  Co-membership gene set networks (M) connect gene sets if there is a 
significant number of shared genes between the two gene sets. Linkage gene set 
networks (L) connect a pair of gene sets if there is a significant number of gene or protein 
interactions between the unique genes of the two gene sets. Co-enrichment gene set 
networks (E) connect gene sets if there is a significant number of experiments where the 
unique genes of the two gene sets are enriched together. 
Even though several types of gene set networks for humans have been proposed, to our 
knowledge, none of them contains directionality information in a gene set network.  
Therefore, in this study we proposed a method to construct a regulatory gene set network 
(R), a directed network, which reveals novel relationships among gene sets together with 
directionality information. A regulatory gene set network was constructed by using 
publicly available gene regulation data. A directed edge in regulatory gene set networks 
represents a regulatory relationship from one gene set to the other gene set. The 
significant value of each edge was computed by using hypergeometric distribution and 
was corrected for multiple comparison using BH-procedure [3]. By comparing a regulatory 
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gene set network (R) with a linkage gene set network (L), which is constructed from 
protein interactions discarding directionality of the interactions, a regulatory gene set 
network contains higher resolution of knowledge. Our hypothesis is a regulatory gene set 
network can reveal novel gene set relationships and provide complement knowledge to 
the existing types of gene set networks such as co-membership and linkage. Therefore, a 
regulatory gene set network can facilitate system biology to understand biological 
phenomena through global regulatory gene set network construction and disease specific 
regulatory gene set network construction. 
Moreover, several tools have been developed to enable identification of gene set 
relationships. For example, Sudhir, et al. developed HPD database to enable study of 
human pathway crosstalk networks [7]; Huang, et al. developed PAGED, a pathway and 
gene-set enrichment database to enable molecular phenotype discoveries [19]; and 
Jignesh, et al. developed Metanet, a web tool for constructing multi-edge gene set 
networks which consist of three types of edges: co-membership, link-age, and co-
enrichment, separately for each gene set collection [32]. While HPD focused only on human 
pathway networks, Metanet and PAGED allowed researchers to construct a gene set 
network. As previously described, a gene set represents a set of genes belonging to the 
same pathway, the same biological process, and the same disease. Therefore, Metanet 
and PAGED provided more coverage and flexibility of gene set network construction. 
However, Metanet constructed a gene set network based only a single gene set collection, 
preventing researchers from searching for relationships among gene sets from different 
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data sources; and PAGED does not allow researchers to visualize a network. In this study, 
we developed Pathway and Annotated Gene-set Electronic Repository (PAGER) in order 
to enable researchers to identify relationships among gene sets from different data 
sources. PAGER also supported constructing a regulatory gene set network (R), which is a 
new type of gene set network we proposed, and supported constructing gene interaction 
and gene regulatory network of genes inside a gene set. 
In summary, this study consists of two parts, constructing a regulatory gene set network 
and developing PAGER to allow users to construct several types of gene and gene set 
networks. A method for constructing a regulatory gene set network was presented, and 
a method for developing PAGER to allow users to construct several types of gene and 
gene set networks was described later. 
1.2 Constructing a Regulatory Gene Set Network 
Gene set data and gene regulation data were collected from several reliable data sources. 
Five co-membership gene set networks were separately construct for each gene set 
collection including KEGG [23], Reactome, Go biological process, GO cellular component, 
and GO molecular function. Because a co-membership gene set network is a common 
type of a gene set network that has been constructed in several studies [27,32], a co-
membership gene set network was used as a baseline to compare with our new type of 
gene set network, a regulatory gene set network. A regulatory gene set network connects 
a pair of gene sets if there is a significant number of gene regulations between the unique 
genes of the gene sets. A regulatory gene set network and a co-membership network 
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were compared in order to show that regulatory gene set network can reveal novel gene 
set relationships and provide complement knowledge to the co-membership gene set 
network. The directionality information provided by a regulatory gene set network was 
used to search for significant gene sets in the network. 
Our KEGG regulatory gene set network was validated with the KEGG co-enrichment gene 
set network obtained from Jignesh, et al. [32]. The KEGG co-enrichment gene set network 
can be used for validation because it was constructed from several differentially 
expressed gene lists obtained from several biological experiments. Because a pair of gene 
set in regulatory network are connected if there is a significant number of gene 
regulations from one gene set to the other gene set, these gene sets should be enriched 
together. Therefore, the number of shared edges between the co-enrichment network 
and the regulatory network should be significantly high. 
In addition, a gene set network was often constructed as a global network. In a global 
gene set network, all gene sets in a gene set collection were presented as nodes in the 
network. However, a gene set network specific to a disease can also be constructed in 
order to understand the underlying mechanism of the disease. In this study, Alzheimer’s 
disease (AD) was chosen to use as a case study for our regulatory gene set network. In 
contrast to constructing a global network for each gene set collection, all gene sets from 
different collections were combined into a single collection. We selected AD related gene 
set form the combined gene set collection and constructed an AD specific regulatory gene 
8 
 
8
 
set network. Finally, we showed that the AD specific regulatory gene set network is useful 
for understanding AD. 
1.3 Pathway and Annotated Gene-set Electronic Repository (PAGER) 
PAGER is an online platform for searching gene sets and constructing gene set networks 
to reveal insights into biological systems. Gene set data were collected to increase the 
coverage of PAGER. This first version of PAGER contains 166,489 gene sets integrated 
from 10 different gene set data sources. A global regulatory and a global co-membership 
gene set networks were pre-constructed. PAGER also allowed users to construct gene 
interaction and gene regulation networks of genes inside a gene set. 
 
Figure 1.1 PAGER screenshots 
On PAGER home page (Figure 1.1A), users can search for genes and gene sets by terms 
such as a disease name and a gene symbol. The result gene sets can be added into Gene 
Set Box, a space for users to save their gene sets. A status of Gene Box and Gene Set Box 
were display on the top right of the page. When users enter terms, the number genes and 
gene sets which matched, in different aspects, to the terms were displayed in overall 
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result page (Figure 1.1B). PAGER also allows users to search for gene sets which related 
to their gene lists. Users entered a list of genes, then PAGER returned a list of related gene 
sets and p-values (Figure 1.1C). The result gene sets can be sorted by name, size of gene 
set, number of genes found in the list, and p-value. Users can add gene sets to Gene Set 
Box and construct and visualize a co-membership and a regulatory gene set networks of 
gene sets in Gene Set Box (Figure 1.1D). Users can select a gene set node in the networks 
to see more detail (Figure 1.1E). On a gene set detail page, users can see detail of a gene 
set and construct a gene interaction network and a gene regulation network of genes 
inside a gene set.  
Furthermore, PAGER allows users to expand gene set networks from a gene set of interest 
in the existing network. The ability to expand gene set networks has not provided before 
in other existing tools. For each selected gene set, PAGER enables users to construct three 
types of expanded gene set network, including networks of upstream, downstream, and 
co-membership gene sets. Upstream gene sets are gene sets which regulate the selected 
gene set; downstream gene sets are gene sets which are regulated by the selected gene 
set; and co-membership gene sets are gene sets which share significant number of genes 
with the selected gene set. Constructing expanded gene set network allows users to find 
more gene set related to their study. For example, users constructed gene set networks 
of 10 gene sets and were interested in one of the 10 gene sets which was regulated by 
many gene sets. In this example, PAGER allows users to further search for downstream 
gene set of the gene set of interest. Because PAGER enables users to construct gene 
10 
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networks, users can also construct expanded gene networks from a gene as well. Three 
types of expanded gene networks provided by PAGER are networks of upstream, 
downstream, and sibling genes. Upstream genes are genes which regulate the selected 
gene; downstream gene are gene which are regulated by the selected gene; and sibling 
genes are gene which interact with the selected gene. 
Finally, we presented six use cases in order to show how PAGER is useful for systems 
biology study. The six use cases are searching genes and gene sets by a disease name, 
searching gene sets by a list of genes, constructing a regulatory and a co-membership 
gene set networks, generating expanded gene set networks for a particular gene set, 
constructing a gene interaction and a gene regulation networks of a gene set, and 
constructing disease specific gene set networks 
1.4 Contribution Summary 
 We proposed a method to construct a new type of gene set network, a regulatory 
gene set network, which reveals novel relationships among gene sets together 
with directionality information. 
 A directed edge in regulatory gene set networks represents a regulatory 
relationship from one gene set to the other gene set, which has never been reveal 
before by other types of gene set networks. 
 By comparing and validating a regulatory gene set network with other existing 
types of gene set networks, we showed that a regulatory gene set network 
provides complement knowledge and useful information. 
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 A regulatory gene set network facilitates understanding biological phenomena 
and underlying mechanism of a disease through global and disease specific 
regulatory gene set network constructions. 
 We developed Pathway and Annotated Gene-set Electronic Repository (PAGER) to 
enable users to construct and visualize regulatory and co-membership gene set 
networks from multiple gene set collections. 
 PAGER contains 166,489 gene sets, 92,108,741 co-membership edges, 
697,221,810 regulatory edges, 44,188 genes, 651,586 unique gene regulations, 
and 650,160 unique gene interactions. 
 Typically, a systems biology tool supports either gene networks construction or 
gene set networks construction. In contrast, PAGER allows users to construct gene 
interaction and gene regulation networks of genes inside a gene set. This feature 
enable users to include both levels of biological networks, gene and gene set 
networks, into their study. 
 PAGER enables users to construct three types of expanded gene set network 
including networks of upstream, downstream, and co-membership gene sets. 
Constructing expanded gene set networks allows users to find more important 
gene sets related to their study. 
 PAGER also allows users to construct expanded gene networks from a gene 
including networks of upstream, downstream, and sibling genes. 
12 
 
1
2
 
 PAGER provides an interactive visualization tool for users to study gene and gene 
set networks and offers spaces, Gene Box and Gene Set Box, for users to store 
their genes and gene sets. 
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CHAPTER 2. METHODS 
2.1 Design 
This study was separated into two parts. The first part is to construct a new type of gene 
set network, a regulatory gene set network. In the first part of methods, we presented a 
framework to construct regulatory gene set networks and a method to show that 
regulatory networks can reveal novel gene set relationships. We also proposed a method 
to construct disease specific regulatory gene set network to reveal novel insights into 
diseases. The second part of this study is developing Pathway and Annotated Gene-set 
Electronic Repository (PAGER) in order to enable identification of gene set relationships 
for systems biology. PAGER is an integrated platform on which users search for gene sets 
and construct co-membership and regulatory gene set networks. 
2.2 Constructing a Regulatory Gene Set Network 
A gene set network is a network where a node represent a set of genes and an edge 
represents a relationship among gene sets. Gene set networks can be used for explaining 
biological complexity by revealing high level relationships between biological processes. 
Typically, gene set networks are undirected networks. In this study, we proposed a 
regulatory gene set network, which is a new type of network. It is a directed network
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where a directed edge represents regulatory relationship from one gene set to the other 
gene set. A regulatory gene set network was constructed by using publicly available gene 
regulation data obtained from several sources. Our hypothesis is regulatory gene set 
network can reveals novel insights into the complex of biological processes. A co-
membership gene set network is another type of network we constructed. It can be a 
basement network because it is construct from annotated gene sets collected from 
sources, which provide experimental validation data.  
Gene set data and gene regulation data were collected from different publicly available 
sources. We filtered only high quality gene regulation data in order to construct a 
regulatory gene set network. Next, regulatory and co-membership gene set networks 
were constructed separately for each of five gene set collections. Hypergeometric 
distribution was used to calculate significant value for each edge in both types of gene set 
networks. We validated our KEGG gene set networks with the KEGG co-enrichment 
network obtained from the study of Jignesh, et al. [32] Finally, we construct a regulatory 
network specific to Alzheimer’s disease (AD).  
2.2.1.1 Gene Set Data Sources 
A gene set is a set of genes which relate to the same biological concepts. Gene set can 
represent several concepts; for example, genes are in the same pathway, genes express 
in the same specific condition, genes are regulated by the same transcription factor or 
miRNA, and genes relate to the same disease. We collected five collections of gene sets 
including KEGG [23], Reactome [22], Go biological process, GO cellular component, and GO 
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molecular function [1]. Gene set data of Reactome, GO Biological Process, GO Cell 
Component, and GO Molecular Function were downloaded from MSigDB [28]. Different 
types of gene ID obtained from different sources were mapped to NCBI official gene 
symbols. The total number of gene set from five gene set collections is 2,825 and the total 
number of genes is 2,304. 
2.2.1.2 Gene Regulation Data Sources 
Gene regulation data was used for constructing regulatory gene set networks. Human 
gene regulations were collected from String [13], TRANSFAC [30], TRED [20], and Spike [33]. 
The total number of gene regulations after combining and filtering data from the four 
data sources is 22,127. Different types of gene ID obtained from different sources were 
mapped to NCBI official gene symbols. In order to select only high quality human gene 
regulation data, different criteria were used to filter gene regulations for different data 
sources (Table 2.1). For String, gene regulations which have score greater than or equal 
to 800 were collected. Gene regulations which have binding site quality less than or equal 
to 5 from TRANSFAC were collected. For TRED, gene regulations which are not obtained 
from computational predicted method were collected. All genes regulations provided by 
Spike were collected because they are from pathways.
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Table 2.1 Human gene regulation data sources 
Data Source Description Download date Publication Criterion 
Spike (2012) 
Gene regulations from 
pathway 
03/01/2013 NAR, 2011 
Collect all gene 
regulations 
TRANSFAC 7.4 
(Public version) 
Transcription Factor 
binding site and genes 
2009 NAR, 2003 
Binding site 
quality <= 5 
TRED 
Transcriptional Regulatory 
Element Database 
03/01/2013 NAR, 2007 
Remove all 
computational 
predicted 
records 
String 9.05 
Protein interaction 
database 
09/04/2013 NAR, 2013 Score >= 800 
 
2.2.2 Constructing Gene Set Networks 
In this study, two types of gene set networks we constructed are co-membership and 
regulatory gene set networks. In a co-membership gene set network, two gene sets were 
connected if there is a significant number of shared genes. In contrast, in a regulatory 
gene set network, a pair of gene sets were connected if there is a significant number of 
gene regulations between their unique genes. 
2.2.2.1 Co-membership Gene Set Networks 
Co-membership gene set network is a typical type of gene set network which have been 
constructed in several studies [27,32]. Different studies used different methods to calculate 
the significant value; for instance, using Fisher’s exact test to computing a p-value and 
computing an experimental p-value by generating random gene sets. In this study, 
hypergeometric distribution was used to calculate a significant value for each co-
membership edges. The following described steps to construct each edge in a co-
membership gene set network. 
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1. Count the number of genes inside both gene sets, GS1 and GS2. 
2. Count the number of shared genes between GS1 and GS2. 
3. Calculate p-value by using hypergeometric distribution 
 
(2.1) 
where N is the total number of genes; n is the number of genes in GS1; K is the 
number of genes in GS2; and k is the number of shared genes. 
4. Adjust calculated p-values for multiple hypotheses in order to control false 
discovery rate by using the Benjamini–Hochberg procedure with p-value ≤ 0.05 [3]. 
5. Connect a pair of gene sets if the edge was rejected by the Benjamini–Hochberg 
procedure. 
Co-membership networks were separately constructed for each gene set collections. We 
used the co-membership gene set network as a basement network to compare with 
regulatory gene set networks in order to show that the regulatory gene set networks 
reveal novel relationships, which were not found before in the co-membership network. 
2.2.2.2 Regulatory Gene Set Networks 
Our goal for this study is to construct a regulatory gene set network. It is a directed 
network where a node is a gene set and a directed edge represents a regulatory 
relationship from one gene set to the other. Because a regulatory gene set network is a 
directed network, it provides more insights into how different biological processes 
𝑝 − 𝑣𝑎𝑙𝑢𝑒 =  
 
𝐾
𝑘
  
𝑁 − 𝐾
𝑛 − 𝑘
 
 
𝑁
𝑛
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function together. In addition, it facilitates different methods in network analysis; for 
example, finding sink and source gene sets. Publicly available regulation data was used to 
construct a regulatory gene set network. The following described steps to construct each 
directed edge in the network. 
1. Count the number of gene regulations where genes in GS1 regulate genes outside 
GS1 
2. Count the number of gene regulations where genes outside GS2 regulate genes in 
GS2 
3. Remove shared genes from GS1 and GS2 
4. Count the number of gene regulations where the remaining genes in GS1 regulate 
the remaining genes in GS2. 
5. Calculate p-value by using hypergeometric distribution using Equation 2.1 where 
N is the total number of gene regulations; n is the number of gene regulations 
where genes in GS1 regulate genes outside GS2; K is the number of gene 
regulations where genes in GS2 are regulated from genes outside GS2; and k is the 
number of gene regulations from genes in GS1 to GS2. 
6. Adjust calculated p-values for multiple hypotheses in order to control false 
discovery rate by using the Benjamini–Hochberg procedure with p-value ≤ 0.05. 
7. Connect a pair of gene sets with directed edge pointing from GS1 to GS2 if the 
edge is rejected by the Benjamini–Hochberg procedure. 
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Regulatory networks were separately constructed for each gene set collection. In order 
to compare the regulatory network, a directed network, with the co-membership 
network, an undirected network, the regulatory gene set network was converted to an 
undirected network by discarding the direction of edges and removing loop.  
2.2.2.3 Hypergeometric Distribution 
The hypergeometric distribution is a discrete probability distribution that describes the 
probability of 𝑘 successes in 𝑛 draws without replacement from a finite population of size 
𝑁 containing exactly 𝐾 successes [34]. Equation 2.1 shows the probability mass function 
(pmf) of the hypergeometric distribution. The pmf was used for calculating p-value of all 
edges in gene set networks. 
2.2.2.4 Benjamini–Hochberg Procedure 
Benjamini–Hochberg procedure or BH procedure is a method to control the False 
Discovery Rate for multiple comparisons [3]. False Discovery Rate (FDR) is the expected 
percent of false predictions in the set of predictions. For this study, the set of predictions 
is a set of edges in a gene set network. The q-value that we use for this study is 0.05, so 
we expected that 95 percent of predicted edges to be correct. 
Consider testing 𝐸1, 𝐸2, … , 𝐸𝑚 based on the corresponding p-values 𝑃1, 𝑃2, … , 𝑃𝑚 . Let 
𝑃(1) ≤ 𝑃(2) ≤ ⋯ ≤ 𝑃(𝑚)  be the ordered p-values, and denote by 𝐸𝑖 the null hypothesis 
corresponding to 𝑃(𝑖). Let 𝑘 be the largest 𝑖 for which 𝑃(𝑖)  ≤  
𝑖
𝑚
𝑞 then reject all 𝐸𝑖 where 
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𝑖 =  1, 2, … , 𝑘 . Therefore, two gene sets were connected if their incident edge was 
rejected by the BH procedure. 
2.2.3 A Disease Specific Gene Set Network 
A disease specific regulatory gene set network was constructed in order to show that the 
network can help researchers to understand a disease. Alzheimer’s disease (AD) was 
chosen to use as a case study. First, an AD gene list was obtained from Alzgene database 
[4]. Then the list was used to select AD related gene sets from all five gene set collections. 
Finally, an AD specific regulatory gene set network was constructed by using the AD 
related gene sets. 
In order to find AD related gene sets, we counted the number of genes in each gene set 
which were found in AD gene list. We treated an AD gene list as a new gene set, an AD 
gene set. We used the same method as constructing a co-membership network to 
calculate a p-value for each gene set. Only gene sets which shared a significantly high 
number of genes with the AD gene set were selected. 261 gene set were selected to be 
AD related gene sets and were used to construct an AD specific regulatory gene set 
network. 
2.2.4 Network Analysis 
After co-membership and regulatory gene set networks were constructed, we calculated 
several types of centrality values for each gene set in both networks. igraph software 
package for R [8] was used in order to compute all network values. 
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2.2.4.1 Degree Centrality 
Degree centrality represents the number of edges incident upon a node. Degree centrality 
value of each gene set in a gene set network is equal to degree of a gene set normalized 
by the number of total gene sets in the network. A gene set which has high degree 
centrality is likely to be an important gene set because it acts like a hub in the network. 
In addition, a degree centrality of each node can be used for comparing two different 
types of networks, co-membership and regulatory gene set networks. In order to perform 
this comparison, Pearson’s correlation coefficient of degree centrality between co-
membership and regulatory gene set networks was calculated. 
In addition, because regulatory gene set network is a directed network, indegree 
centrality and outdegree centrality were also calculated for future analysis. 
2.2.4.2 Betweenness Centrality 
Betweenness centrality of a node is defined by the number of times a node acts as a 
bridge along the shortest path between two other nodes. In gene set network, a gene set 
which has high betweenness value is likely to be a part of several biological critical paths. 
igraph was used to calculate betweenness for each gene set in the networks. The 
betweenness of a gene set, 𝑣, is defined by 
𝐶𝐵(𝑣) =  ∑
𝜎𝑠𝑡(𝑣)
𝜎𝑠𝑡
𝑠≠𝑣≠𝑡∈𝑉
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where 𝑉 is a set of gene sets in a network; 𝜎𝑠𝑡 = 𝜎𝑡𝑠 denote the number of shortest paths 
from 𝑠𝜖𝑉 to 𝑡𝜖𝑉 and 𝜎𝑠𝑠 = 1 by convention; 𝜎𝑠𝑡(𝑣) denote the number of shortest paths 
from 𝑠 to 𝑡 that some 𝑣 lies on [5]. 
In case of a regulatory gene set network, which is a directed network, directionality was 
considered while determining the shortest paths. 
2.2.4.3 Closeness Centrality 
Closeness centrality of a node is defined by the number of steps required to access every 
other nodes from a given node. A node with lower total distance to all other nodes is 
more central; and the higher closeness value the closer to other gene sets. In a gene set 
network, if a gene set, which has high closeness value, is disturbed, it is likely that higher 
number of gene sets will be affected. 
igraph was used to calculate closeness for each gene set in the networks. The 
betweenness of a gene set, 𝑣, is defined by 
𝐶𝐶(𝑣) =  
1
∑ 𝑑𝐺(𝑣, 𝑡)𝑡∈𝑉
 
where 𝑑𝐺(𝑣, 𝑡)  denote the distance between vertices 𝑣  and 𝑡  and 𝑑𝐺(𝑣, 𝑣) = 0  
[5]. 
Normalization is performed by multiplying the raw closeness by 𝑛 − 1, where 𝑛 is the 
number of gene sets in a network. 
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In case of a regulatory gene set network, which is a directed network, directionality was 
considered while determining the shortest paths. In addition, in order to see the effect of 
a particular gene set, we considered only outgoing paths from a given gene set. 
2.2.4.4 Network Comparison 
Pearson’s correlation coefficient (r) measures the linear correlation between two 
variables X and Y. We compared regulatory and co-membership gene set network by 
calculating Pearson’s correlation coefficient of their degree centrality values. The value of 
Pearson’s correlation coefficient is between +1 and -1, where 1 is total positive correlation 
suggesting that the two types of networks highly correlated in degree centrality aspect. 
2.3 Pathway and Annotated Gene-set Electronic Repository (PAGER) 
In the previous section, we explained the framework to construct the regulatory gene set 
network. In order to enable users to construct gene set network corresponding to their 
studies, we developed PAGER, an online platform for searching gene sets and 
constructing gene set networks. First, more gene set data were collected to increase the 
coverage of PAGER. Global regulatory and global co-membership gene set networks were 
pre-constructed. In addition, two types of gene networks provided by PAGER are gene 
interaction and gene regulation networks. The gene networks are networks within a gene 
set node and are useful for users to study about a particular gene set. In addition, 
interactive network visualization has been developed for displaying both gene and gene 
set networks. Users can also search for a particular gene set within a gene set network 
and select multiple gene sets in order to construct a new network. Moreover, users can 
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search for gene sets related to their gene list and construct co-membership and 
regulatory gene set networks of the related gene sets. 
2.3.1 Data Sources 
2.3.1.1 Gene Set Data Sources 
In order to implement high coverage pathway and gene set repository, we collected more 
gene set data from additional sources. The total number of gene sets is 187,076 obtained 
from 10 different sources (Table 2.2). 166,489 gene sets obtained from GAD have size of 
1. We counted a disease-gene relationship obtained from GAD as a gene set because it 
was collected from different publications. The disease associated genes were not grouped 
together because it is obtained from different experiments. Gene set information from 
GAD enables users to find more disease related genes. In this study, gene set data was 
collected by several methods including directly download from the database and 
implement Java web crawler to retrieve information. Different types of gene ID were 
mapped into the NCBI official gene symbols. 
2.3.1.2 Gene Interaction and Gene Regulation Data Sources 
Human gene regulation data from Table 2.1 was imported into a database. Additional 
human gene interaction data was downloaded from String 9.01 to support gene 
interaction network construction.
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Table 2.2 List of gene set data sources 
Source Name Description Download 
Date 
Number of 
Gene Sets 
GAD [2] Genetic Association Database 8/26/2013 166,489 
GWAS Catalog 
[17] 
A Catalog of Published Genome-Wide 
Association Studies provided by NHGRI 
8/27/2013 1,574 
GeneSigDB [9] GeneSigDB: a manually curated 
database and resource for analysis of 
gene expression signatures 
8/23/2013 3,515 
MSigDB [28] The Molecular Signatures Database is a 
collection of annotated gene sets for 
use with GSEA software 
8/26/2013 10,295 
NGS Catalog [38] NGS Catalog: A database of next 
generation sequencing studies in 
humans 
8/26/2013 69 
OMIM [15] Online Mendelian Inheritance in Man 8/27/2013 4,409 
PharmGKB [37] The Pharmacogenomics Knowledge 
Base 
8/26/2013 102 
Protein Lounge Bioinformatics portal which integrates 
protein information, databases and 
research tools for researchers and 
students 
2009 393 
Spike [33] SPIKE is a database of highly curated 
human signaling pathways 
9/5/2013 28 
WikiPathway [24] WikiPathways is an open, public 
platform dedicated to the curation of 
biological pathways by and for the 
scientific community 
8/26/2013 202 
 
2.3.2 Database Design 
Database schema was designed after all gene set, gene regulation, gene interaction data 
were collected (Figure 2.1). In current version, subscription function has not available yet. 
Some tables which are important for gene set network construction including: GENESET 
is a table of gene set detail; GS_GS_OVERLAP is a table of co-membership edges; 
GS_GS_REG is a table of regulatory edges. GENE_GENE_INT is a table of gene interactions; 
and GENE_GENE_REG is a table of gene regulations. The number of total co-membership 
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edges discarding p-value is 92,108,741 and the number of total regulatory edges 
discarding p-value is 697,221,810. 
 
Figure 2.1 PAGER ER Diagram 
2.3.3 Implementation 
In order to implement PAGER, several programming languages and web technologies 
were used. The implementation followed Model-View-Controller software pattern and a 
programming framework was used for expandability. PAGER was implemented by using 
PHP language version 5 and Codeigniter version 2.1.3 [12] which is an application 
development framework for building web sites.  
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PAGER data was stored in Oracle 12g database maintained by Indiana University and was 
connected to PHP server by Oracle Instant Client software [21]. P-value for each edge in 
gene set networks was computed on-the-fly by using hypergeometric function provided 
by PDL [31], a PHP library for mathematics. For gene and gene set networks visualization 
in PAGER, cytoscape.js, an open-source graph library [6], and jQuery was used for 
implementing interactive networks. 
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CHAPTER 3.  RESULTS 
3.1 Constructing a Regulatory Gene Set Network 
3.1.1 Gene Set Networks 
Gene set networks reveal insights into relationships among different biological processes. 
In this study, for each gene set collection, we constructed a co-membership gene set 
network, a well study type of gene set network, and a regulatory gene set network, a new 
type of gene set network. Co-membership gene set networks connect a pair of gene sets 
if there is a significant number of shared genes. Therefore, constructing co-membership 
gene set network requires only curated gene set definition from gene set data sources. A 
co-membership gene set network can be a baseline for comparison with other types of 
gene set networks to evaluate gaining of novel insights. In this study, the goal is to 
construct a regulatory gene set network, a new type of gene set network, by using publicly 
available gene regulations (Table 3.1). Regulatory gene set networks connect a pair of 
gene sets when there is a significant number of gene regulations between the genes of 
the two gene sets. In order to construct gene set regulatory network, we collected gene 
regulation data from 4 different data sources including String 9.05 [13], TRANSFAC [30], 
TRED [20] and Spike [33].
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Two types of gene set network have different interpretations. When a pair of gene sets 
in co-membership gene set network are connected, the interpretation depends on types 
of gene sets. For pathway gene sets, co-membership networks represent pathway 
crosstalk; for GO gene sets, an edge in co-membership networks represents protein 
moonlighting or gene sharing. In contrast, when a pair of gene sets in regulatory gene set 
networks are connected, they are connected by a directed edge. The directed edges in a 
regulatory gene set network present a possibility of one gene set regulates other gene 
set. 
Table 3.1 Summary of co-membership gene set networks and regulatory gene set 
networks for five gene set collections 
Collection 
Number of 
gene sets 
co-membership 
edges 
Regulatory 
edges 
Regulatory 
relationships 
Shared 
edges 
KEGG 186 2,230 4,452 3,274 1,461 
Reactome 674 15,859 25,569 20,917 7,437 
GO BP 825 33,055 32,607 27,513 10,354 
GO CC 223 4,186 1,446 1,122 793 
GO MF 396 3,178 2,620 2,404 503 
 
A pair of gene sets can have a loop if both incoming edge and outgoing edge are significant, 
so there can be two edges for a pair of gene sets. Therefore, the number of regulatory 
edges is always grater or equal to number of regulatory relationships because each pair 
of gene sets either has or do not have regulatory relationship. 
For regulatory gene set networks, GO Biological Process (32,607 edges and 825 nodes), 
Reactome Pathway (25,569 edges and 674 nodes) have the highest proportion of edges 
to nodes among the five gene set collections (Table 3.1). In addition, by considering the 
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proportion of edges to nodes among three GO collections, GO Biological Process has the 
highest proportion, while GO Cellular Component (1122 edges and 223 nodes) and GO 
Molecular Function (2404 edges and 396 nodes) have relatively low proportion. These 
results suggested that pairs of biological processes are more likely to have regulatory 
relationships. 
The low percentages of shared edges indicated that regulatory gene set networks provide 
complementary knowledge to co-membership gene set networks. It is worth to note that 
regulatory gene set networks were constructed from high quality gene regulation data, 
which were collected from high coverage data sources. Therefore, regulatory gene set 
networks unlikely depend on the number and the quality of experimental data. 
Considering both co-membership and regulatory networks of KEGG pathway gene sets, 
the most significant edge of the KEGG regulatory gene set network is a regulatory 
relationship from “Cell cycle” to “Cytokine-cytokine receptor interaction” with significant 
value 6.46E-75 (Table 3.2). While a co-membership edge between “Cell cycle” to 
“Cytokine-cytokine receptor interaction” has relatively lower significant value, 0.029. In 
addition, only 4 of the top 10 most significant regulatory edges were found in the KEGG 
co-membership network. These findings suggested that the regulatory gene set network 
reveals additional knowledge to the co-membership gene set network. 
For the KEGG regulatory gene set network, 7 of the 10 most significant regulatory edges 
are from “Cell cycle” gene set to other 7 KEGG pathway gene sets, including “Cytokine-
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cytokine receptor interaction”, “Pathways in cancer”, “Toll-like receptor signaling 
pathway”, “Focal adhesion” and “Leishmania infection” (Table 3.2). These results 
suggested that changing in “Cell cycle” pathway likely affects other pathways. These 
results were also corresponding to the fact that cell cycle is the complex series of 
phenomena by which cellular material is duplicated and divided. If cell cycle pathway does 
not appropriately function, several pathways can be affected such as Pathways in Cancer. 
Table 3.2 Top 10 most significant regulatory edges in the KEGG regulatory gene set 
network where gene set 1 regulates gene set 2 
Gene set 1 name Gene set 2 name P-value 
Cell cycle Cytokine-cytokine receptor interaction 6.46E-75 
Cell cycle Pathways in cancer 5.31E-55 
Cell cycle Toll-like receptor signaling pathway 1E-42 
Cell cycle Focal adhesion 2.22E-36 
Cell cycle Leishmania infection 2.63E-33 
Hedgehog signaling pathway Basal cell carcinoma 3.08E-33 
p53 signaling pathway Cytokine-cytokine receptor interaction 3.38E-33 
RIG-I-like receptor signaling 
pathway 
Toll-like receptor signaling pathway 3.39E-33 
Cell cycle Hematopoietic cell lineage 8.26E-33 
Cell cycle Jak-STAT signaling pathway 1.08E-31 
 
For co-membership network, the KEGG pathway gene sets of “Alzheimer’s disease”, 
“Parkinson’s disease” and “Huntington’s disease” have significant co-membership edges 
link them together (Table 3.3). The three co-membership edges connecting the 
neurodegenerative diseases were in the top 10 most significant co-membership edges 
suggesting that the three neurodegenerative diseases are highly related. In addition, 5 
edges of the top 20 co-membership edges were connecting cancer related pathway gene 
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sets. The 5 edges are “Pathways in cancer” gene set connects to 5 cancer gene sets 
including “Small cell lung cancer”, “Pancreatic cancer”, “Melanoma”, “Colorectal cancer 
and “Prostate cancer”. 
Table 3.3 Top 10 most significant co-membership edges in  
the KEGG co-membership gene set network 
Gene set 1 name Gene set 2 name P-value 
Dilated cardiomyopathy Hypertrophic cardiomyopathy (HCM) 2.9E-134 
Oxidative phosphorylation Parkinson's disease 5E-132 
Huntington's disease Parkinson's disease 2.2E-124 
Alzheimer's disease Parkinson's disease 8.9E-113 
Drug metabolism - cytochrome 
P450 
Metabolism of xenobiotics by 
cytochrome P450 
2.5E-110 
Alzheimer's disease Huntington's disease 1.5E-106 
Alzheimer's disease Oxidative phosphorylation 1.5E-101 
Huntington's disease Oxidative phosphorylation 1.02E-96 
Pathways in cancer Small cell lung cancer 2.94E-91 
Arrhythmogenic right ventricular 
cardiomyopathy (ARVC) 
Hypertrophic cardiomyopathy (HCM) 1E-89 
 
3.1.2 Comparing the KEGG Regulatory and the KEGG Co-membership Network 
In the co-membership gene set network of KEGG, an edge between pathways can be 
considered as pathway crosstalk, a well-studied phenomenon [7,27,32]. In contrast to the 
co-membership network, the regulatory network revealed regulatory relationships 
between pathways, for example, dysfunction of one pathway might affect function of 
another pathways. In order to show that regulatory gene set network provide 
complementary information to the co-membership gene set network, we compare co-
membership gene set network and regulatory gene set network of the KEGG pathways.  
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The KEGG pathway data downloaded from MSigDB version 3.1 contains 186 pathways 
which are considered as gene sets and 872 genes. For the KEGG co-membership gene set 
network, 2,230 co-membership edges were constructed where the total number of 
possible pairs of gene sets is 17,205. For the KEGG regulatory gene set network, 4,452 
regulatory edges were constructed where the total number of possible pairs of gene sets 
is 34,410 because the regulatory network is a directed network. However, if we count 
only the regulatory relationship between a pair of gene sets by discarding the direction, 
there were 3,274 relationships. Directionality information in the KEGG regulatory gene 
set network was discarded in order to compare with the co-membership gene set 
network which is an undirected network. 1,461 edges were found in both the KEGG co-
membership gene set network and the KEGG regulatory gene set network. The proportion 
of shared edges to co-membership edges is 65.52% (1461/2230) and the proportion of 
shared edges to regulatory relationships is 44.62% (1461/3274). 
Besides comparing the two networks by counting shared edges, degree centrality (DC) of 
each gene set node in both networks were calculated (Table 3.4). In the KEGG co-
membership network, “Pathways in cancer” gene set has the highest value of degree 
centrality, 0.39, while in the KEGG regulatory gene set network, “Cell cycle” gene set has 
the highest value of degree centrality, 1.96, and the highest outdegree centrality, 0.65. 
The gene set which has the highest indegree centrality, 0.41, is “Pathways in cancer”. 
Note that degree centrality value of regulatory gene set network can be greater than 1 
because regulatory network is a directed network. 
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Table 3.4 Top 10 highest degree centrality pathway of KEGG co-membership gene set 
network (left) and KEGG regulatory gene set network (right) 
KEGG co-membership network KEGG regulatory network 
Name DC Name DC 
Pathways in cancer 0.39 Cell cycle 1.96 
MAPK signaling pathway 0.36 T cell receptor signaling 
pathway 
1.55 
T cell receptor signaling pathway 0.36 Chemokine signaling pathway 1.49 
Chemokine signaling pathway 0.36 ErbB signaling pathway 1.48 
Natural killer cell mediated 
cytotoxicity 
0.36 p53 signaling pathway 1.48 
Fc epsilon RI signaling pathway 0.34 Pathways in cancer 1.47 
Progesterone-mediated oocyte 
maturation 
0.34 Bladder cancer 1.46 
GnRH signaling pathway 0.34 Neurotrophin signaling 
pathway 
1.45 
Colorectal cancer 0.33 Chronic myeloid leukemia 1.43 
Prostate cancer 0.33 Focal adhesion 1.43 
 
 
Figure 3.1 Correlation between degree centrality of the KEGG co-membership network 
and degree centrality of the KEGG regulatory network. 
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After a degree centrality value for each gene set was calculated, we calculated a 
correlation between degree centrality of the KEGG co-membership network and degree 
centrality of the KEGG regulatory network. The correlation coefficient is 0.84 and R-
squared value is 0.70 (Figure 3.1). This result suggested that the gene set, which is 
important in a co-membership gene set network, is likely to be important in a regulatory 
gene set network. In addition, three interesting outliers were found in Figure 3.1. Pathway 
number 1, which has regulatory DC = 1.96 and co-membership DC = 0.12, is “Cell cycle”, 
suggesting that Cell cycle pathway does not tend to share genes with other pathways, but 
tends to regulate other pathways. Pathway number 2, which has regulatory DC = 1.47 and 
co-membership DC = 0.39 is “Pathways in cancer”, suggesting that Pathways in cancer 
shared high number of genes with several pathways and its genes also regulate the unique 
genes of other pathways. Pathway number 3, which has regulatory DC = 0.68 and co-
membership DC = 0.005, is “Maturity onset diabetes of the young”. “Maturity onset 
diabetes of the young” pathway only shares 6 genes with “Type II diabetes mellitus 
pathway”. While the correlation between degree centrality of the KEGG co-membership 
network (M) and degree centrality of the KEGG regulatory network (R) is high, 0.84, the 
topology of the networks are different (Figure 3.2). These results suggested that two 
types of networks can be used to explain different biological phenomenon. The networks 
were layout using Edge-Weighted Spring Embedded Layout according to p-value in 
Cytoscape software. 
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Figure 3.2 (M) KEGG co-membership network and (R) KEGG regulatory network. 
We further constructed a KEGG exclusive regulatory gene set network (R-M) which 
contains only exclusive edges in the KEGG regulatory gene set network (Figure 3.3).  The 
correlation of degree centrality between the KEGG exclusive regulatory gene set network 
(R-M) and the KEGG regulatory gene set network (R) is 0.81. The correlation of degree 
centrality between the KEGG exclusive regulatory gene set network (R-M) and the KEGG 
co-membership gene set network (M) is 0.44 which is relatively low comparing to the 
correlation between degree centrality of the KEGG co-membership network (M) and 
degree centrality of the KEGG regulatory network (R). These results suggested that 
constructing an exclusive regulatory gene set network reveals important gene sets which 
are not likely to be revealed by constructing a co-membership gene set network. 
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Figure 3.3 R-M is KEGG exclusive regulatory network. Node colors represents different 
classes of pathways. 
 
A degree centrality of each gene set in the KEGG exclusive regulatory network was 
calculated by considering both indegree and outdegree (Table 3.5). The “Cell cycle” gene 
set still has the highest value of degree centrality, 0.78. In addition, degree centrality of 
the top 10 gene sets in the KEGG co-membership gene set network (M DC) are relatively 
low; however, degree centrality of the top 10 gene sets in the KEGG regulatory gene set 
network (R DC) are relatively high. These results also suggested that constructing 
exclusive regulatory gene set network reveals important gene sets which are not likely to 
be revealed by constructing co-membership gene set network. 
An indegree centrality and an outdegree centrality were also calculated for each gene set 
in the KEGG exclusive regulatory gene set network (Table 3.6). The directionality 
information from a regulatory gene set network revealed “sink” and “source” gene sets 
in addition to “hub” gene sets. 
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Table 3.5 Top 10 highest degree centrality pathway of  
the KEGG exclusive regulatory gene set network 
Name R-M DC M DC R DC 
Cell cycle 0.78 0.12 1.96 
p53 signaling pathway 0.59 0.10 1.48 
TGF-beta signaling pathway 0.44 0.11 1.18 
Bladder cancer 0.43 0.25 1.46 
Cytokine-cytokine receptor interaction 0.42 0.19 1.42 
Chronic myeloid leukemia 0.37 0.31 1.43 
Small cell lung cancer 0.37 0.27 1.37 
Huntington's disease 0.36 0.13 0.89 
Jak-STAT signaling pathway 0.35 0.24 1.32 
Non-small cell lung cancer 0.34 0.29 1.42 
 
Table 3.6 Top 10 highest outdegree centrality pathways (right) and top 10 highest 
indegree centrality pathways (left) of the KEGG exclusive regulatory gene set network 
Name DC (out) Name DC (in) 
Cell cycle 0.54 Cell cycle 0.24 
p53 signaling pathway 0.44 Hematopoietic cell lineage 0.21 
TGF-beta signaling pathway 0.37 Cytokine-cytokine receptor 
interaction 
0.20 
Bladder cancer 0.32 Systemic lupus erythematosus 0.17 
Small cell lung cancer 0.25 Leishmania infection 0.17 
Chronic myeloid leukemia 0.24 Basal cell carcinoma 0.17 
Jak-STAT signaling pathway 0.24 Cell adhesion molecules (CAMs) 0.17 
Huntington's disease 0.24 Graft-versus-host disease 0.17 
Non-small cell lung cancer 0.23 Viral myocarditis 0.16 
Wnt signaling pathway 0.22 p53 signaling pathway 0.15 
 
3.1.3 Comparison of the KEGG Regulatory and the KEGG Co-enrichment Networks 
Two types of networks, co-membership gene set network (M) and regulatory gene set 
network (R), were constructed for KEGG pathways. Our hypothesis is regulatory gene set 
networks can reveal novel knowledge for understanding systems biology. The KEGG co-
membership gene set network was used as a basement and to compare with the KEGG 
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regulatory gene set network. We presented that several relationships between gene sets 
were found exclusively in regulatory gene set network. In order to validate both KEGG co-
membership network and KEGG regulatory network, we compared these two gene set 
networks with the KEGG co-enrichment network (E) obtained from the study of Jignesh, 
et al. [32] In order to construct co-enrichment network, Jignesh, et al. integrated 
experimental gene lists. Two gene sets were connected if the unique genes of the two 
gene sets are consistently enriched together across many experimentally derived gene 
lists. The definition of the co-enrichment gene set network suggested that edges found in 
the KEGG regulatory network should also been found in the KEGG co-enrichment network.  
Because our KEGG regulatory gene set network is a directed network, while the KEGG co-
enrichment gene set network is an undirected network, the regulatory network was 
converted to an undirected network. The total number of edges in the co-enrichment 
network is 1,556 and the total number of edges in the converted regulatory network is 
3,274. The KEGG regulatory network and the KEGG co-enrichment network were 
compared. We found that the total number of edges found in both co-enrichment and 
regulatory networks is 1,050 which is equal to 67.48% of the total number of edges in the 
co-enrichment network. We also compared the KEGG co-membership network with the 
KEGG co-enrichment network and found that the total number of edges are found in both 
co-enrichment and co-membership networks is 914 which is equal to 58.74% of the total 
number of edges in the co-enrichment network.  
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In order to calculate significant value of the number of shared edges, the KEGG co-
enrichment network was compared with random networks. We randomly generated 
1,000 networks using 187 gene sets from KEGG. In order to calculate significant value of 
the number of shared edges between KEGG co-enrichment network (E) and KEGG co-
membership network (M), each of the 1,000 random network has 2,230 edges, which is 
equal to the number of edges found in the KEGG co-membership network (M). Then 
Fisher’s exact test was used for calculating p-value for the number of shared edges; and 
the p-value is < 2.2e-16 (Figure 3.4A). Next, for calculating significant value of the number 
of shared edges between KEGG co-enrichment network (E) and the converted KEGG 
regulatory network (R), each of the 1,000 random network contains 3,274 edges which is 
equal to the number of edges found in the converted regulatory network (R). Then 
Fisher’s exact test was used for calculating p-value for the number of shared edges and 
the p-value < 2.2e-16 (Figure 3.4B) 
For the number of shared edges between the 2,230 random network and KEGG co-
enrichment network (Figure 3.4A); the average and median is 197; the minimum is 162; 
and the maximum is 236. For the number of shared edges between the 3,274 random 
network and KEGG co-enrichment network (Figure 3.4B); the average and median is 289; 
the minimum is 240; and the maximum is 333. 
The number of shared edges between the KEGG co-enrichment network and the KEGG 
regulatory network is significantly high. This result is corresponding to the fact that a pair 
of gene sets which have a significant regulatory relationship should be connected with a 
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co-enrichment edge. The number of shared edges between the KEGG co-enrichment 
network and the KEGG co-membership network is also significantly high. This result is 
corresponding to the fact that a pair of gene sets which has high number of shared genes 
should be connected with a co-enrichment edge. 
 
Figure 3.4 (A) Number of edges in a KEGG co-enrichment network which shared with a 
KEGG co-membership and random networks. (B) Number of edges in a KEGG co-
enrichment network that shared with a KEGG regulatory and random networks.  
 
3.1.4 A Disease Specific Regulatory Gene Set Network 
We already presented that a regulatory gene set network provides additional insights into 
a co-membership gene set network. We also validated the KEGG regulatory gene set 
network and the KEGG co-membership gene set network using the KEGG co-enrichment 
gene set [32]. Furthermore, a regulatory gene set network specific to Alzheimer's disease 
(AD) was constructed. First, 347 AD associated genes were obtained from Alzgene 
database [29]. These genes were used to select gene sets, from all five collections, which 
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are associated with AD. We counted the number of shared genes between the AD gene 
list and each gene set in the five collections. The same method as constructing co-
membership networks was used to calculate significant value of the number of shared 
genes. 261 out of 2,314 gene sets in the five collections have significant number of shared 
genes. For the 261 AD gene sets, 42 gene sets are from KEGG, 59 gene sets are from 
Reactome, 37 gene sets are from GO Molecular Function, 105 gene sets are from Go 
Biological Process, and 18 gene sets are from GO Cellular component. Among the 261 AD 
gene sets, 2 gene sets, “Alzheimer's disease” from KEGG and “amyloid precursor protein 
metabolic process” from GO Biological Process, were annotated that they are associated 
with AD. Next, a regulatory gene set network specific to AD was constructed by counting 
number of gene regulation between every pair of the 261 AD gene sets (Figure 3.5) 
 
Figure 3.5 AD regulatory gene set network 
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The AD regulatory gene set network contains 261 gene sets and 15,178 regulatory edges. 
A node color represents a collection of gene sets. Green represents KEGG; blue represents 
Reactome; yellow represents GO Biological Process; pink represents GO Cellular 
Component; and gray represents GO Molecular function. Three charts presented degree 
distribution (top), indegree distribution (bottom left), and outdegree distribution (bottom 
right). Top 10 highest degree centrality gene sets were investigated (Table 3.7). “signal 
transduction” from GO biological process has the highest value of degree centrality (DC) 
suggesting that signal transduction process is very important in AD. By searching on 
PubMed [16], there were more than two thousand publications discussing about a 
relationship between signal transduction abnormality and Alzheimer’s disease. In 
addition, Liu, et al.[29] studied AD related KEGG pathways and reported top 5 pathways 
for each of 6 brain regions and “Cytokine-cytokine receptor interaction”, which has the 
second highest degree centrality, are among the top 5 of 4 brain regions. 
Table 3.7 Top 10 highest degree centrality gene sets among 261 AD gene sets 
Name Collection DC DC in DC out 
signal transduction GO biological process 1.07 0.62 0.45 
Cytokine-cytokine receptor 
interaction 
KEGG gene sets 0.97 0.53 0.44 
intracellular signal transduction GO biological process 0.97 0.47 0.49 
protein metabolic process GO biological process 0.96 0.43 0.54 
T cell receptor signaling pathway KEGG gene sets 0.95 0.44 0.51 
cellular protein metabolic process GO biological process 0.94 0.40 0.54 
receptor binding GO molecular function 0.94 0.44 0.49 
cellular macromolecule metabolic 
process 
GO biological process 0.94 0.40 0.54 
apoptotic process GO biological process 0.93 0.44 0.49 
programmed cell death GO biological process 0.93 0.44 0.49 
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A sub-network of AD regulatory gene set network which contains only the top 10 highest 
DC gene sets was also constructed (Figure 3.6). The sub-network is almost fully connected, 
indicating that gene sets, which have high DC, tend to be connected together to form a 
highly connected network. 
 
Figure 3.6 A sub-network of AD regulatory gene set network which contains only the top 
10 highest DC gene sets from Table 3.7. 
 
Furthermore, closeness and betweenness of each gene sets in the AD regulatory gene set 
network were computed (Table 3.8). Three gene sets from GO biological process 
collection have the highest closeness centrality, 0.184, when considered only outgoing 
edges. The three gene sets are “cellular macromolecule metabolic process”, “cellular 
protein metabolic process”, and “protein metabolic process”. These results suggested 
that inappropriately functions of these three gene sets likely affect high number of gene 
sets or biological processes in AD context.
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Table 3.8 Top 10 highest closeness centrality (out) gene sets  
Name Collection 
Closeness 
(out) 
cellular macromolecule metabolic process GO biological process 0.184 
cellular protein metabolic process GO biological process 0.184 
protein metabolic process GO biological process 0.184 
regulation of apoptotic process GO biological process 0.183 
regulation of programmed cell death GO biological process 0.183 
Genes involved in Signaling by TGF-beta Receptor 
Complex 
Reactome 0.183 
regulation of cellular metabolic process GO biological process 0.183 
regulation of metabolic process GO biological process 0.182 
apoptotic process GO biological process 0.182 
programmed cell death GO biological process 0.182 
 
For betweenness centrality, “Pathways in cancer” from KEGG, “system development” 
from GO biological process, and “Leishmania infection” from KEGG have the highest 
betweenness value 1,225.04, 1,168.99, and 1,146.79, respectively. These results 
suggested that the three gene sets are likely on critical paths of biological functioning in 
AD context. 
Table 3.9 Top 10 highest betweenness centrality gene sets  
Name Collection Betweenness 
Pathways in cancer KEGG 1225.04 
system development GO biological process 1168.99 
Leishmania infection KEGG 1146.79 
signal transduction GO biological process 983.64 
Genes involved in Metabolism of lipids 
and lipoproteins 
Reactome 859.10 
cell proliferation GO biological process 823.84 
Small cell lung cancer KEGG 780.05 
cytoplasm GO cellular component 767.20 
Adipocytokine signaling pathway KEGG 746.16 
lipid metabolic process GO biological process 731.03 
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3.2 Pathway and Annotated Gene-set Electronic Repository (PAGER) 
A regulatory gene set network reveals insights into systems biology. It provided additional 
and higher resolution knowledge to the existing types of gene set networks as we 
presented in the previous sections. It is useful to build a tool for researchers to generate 
their own gene set networks, which relate to their studies. Therefore, we developed 
Pathway and Annotated Gene-set Electronic Repository (PAGER), which provided a 
platform for users to search for gene sets by terms or by a list of genes, construct co-
membership and regulatory gene set networks, and construct gene interaction and gene 
regulation networks of each gene set. PAGER is available at 
http://discern.uits.iu.edu:8340/PAGER/. 
3.2.1 Data Integration 
In order to make PAGER to have high coverage gene set data, gene sets were collected 
from GAD [2], GWAS Catalog [17], NGS Catalog [38], GeneSigDB [9], MSigDB [28], OMIM [15], 
PharmGKB [37], Protein Lounge, Spike [33], and WikiPathway [24] (Table 3.10). The total 
number of gene sets is 187,076. 
According to Table 3.10, gene sets from GAD are all size of 1 because GAD provided 
disease-gene relationship information. Genes, which belong to the same disease, were 
not combined into a gene set because they were from different experiments or studies.  
However, the data integrated from GAD is useful for searching disease related genes in 
order to find disease related gene sets from other sources within PAGER. 
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Table 3.10 Gene set data sources  
Source Name Description 
Download 
Date 
Number of 
Gene Sets 
GAD Genetic Association Database 8/26/2013 166,489 
GWAS Catalog A Catalog of Published Genome-Wide 
Association Studies provided by NHGRI 
8/27/2013 1,574 
GeneSigDB GeneSigDB: a manually curated 
database and resource for analysis of 
gene expression signatures 
8/23/2013 3,515 
MSigDB The Molecular Signatures Database is a 
collection of annotated gene sets for 
use with GSEA software 
8/26/2013 10,295 
NGS Catalog NGS Catalog: A database of next 
generation sequencing studies in 
humans 
8/26/2013 69 
OMIM Online Mendelian Inheritance in Man 8/27/2013 4,409 
PharmGKB The Pharmacogenomics Knowledge 
Base 
8/26/2013 102 
Protein Lounge Bioinformatics portal which integrates 
protein information, databases and 
research tools for researchers and 
students 
7/1/1905 393 
Spike SPIKE is a database of highly curated 
human signaling pathways 
9/5/2013 28 
WikiPathway WikiPathways is an open, public 
platform dedicated to the curation of 
biological pathways by and for the 
scientific community 
8/26/2013 202 
 
Gene regulation data were collected from four sources, which are the same as the four 
sources in the previous section, was integrated into PAGER. However, all gene regulations 
were integrated into PAGER without using any filter. The total number of unique gene 
regulations is 651,568. In addition, gene interactions were downloaded from String [13] in 
order to construct a gene interaction network inside each gene sets. The total number of 
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unique gene interactions is 650,160. Note that gene regulations were also counted as 
gene interactions regardless the direction.  
3.2.2 Gene Set and Gene Set Networks 
In order to construct a global regulatory gene set network which consists of all gene sets 
in PAGER, the 22,127 filtered gene regulations were used. For each gene set, the number 
of gene regulations from genes inside the gene set to genes outside the gene set and the 
number of gene regulations from genes outside the gene set to genes inside the gene set 
were counted. The number of gene regulations between two gene sets were counted for 
every pair of gene sets in PAGER. The total number of regulatory edges discarding the 
significant value is 697,221,810. A global co-membership gene set network was 
constructed by counting the number of shared genes among every pair of gene sets. The 
total number of co-membership edges discarding the significant value is 92,108,741. Due 
to the large number of edges and the limitation of time, the significant value of each edge 
was computed on-the-fly using hypergeometric distribution when users query for a 
particular gene set network. In addition, because gene interactions and gene regulations 
were integrated into PAGER, users can construct gene networks within each gene set in 
the gene set networks. In other words, a gene network is a network within a node of a 
gene set network. 
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3.2.3 PAGER Features 
 
Figure 3.7 PAGER work flow 
 
An overall work flow of PAGER was presented in Figure 3.7. The top part showed two 
types of searching, search by terms and search by a list of genes (Figure 3.8). When users 
search by terms, PAGER returns both genes and gene sets which relate to the terms. 
When users search by a list of genes, PAGER searches for gene set which contains the 
genes in the list and calculates p-value of the number of shared genes between the gene 
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list and gene sets available in PAGER. Functions related to gene networks were in an 
orange rectangle and functions related to gene set networks were in a blue rectangle.   
 
Figure 3.8 PAGER work flow 
 
The main feature of PAGER is enabling users to construct regulatory gene set networks 
(Figure 3.9). Users can search for gene sets either by terms or a list of genes. Users can 
add gene sets into Gene Set Box, which is a space for saving gene sets.  Both regulatory 
and co-membership gene set networks can be constructed for gene sets inside Gene Set 
Box. In addition, for a particular gene set, users can construct gene set networks of 
upstream, downstream, or co-membership gene sets. Upstream gene sets are gene sets 
which regulate the current gene set; downstream gene sets are gene sets which are 
regulated by the current gene set; and co-membership gene sets are gene sets which 
share genes with the current gene set. Therefore, PAGER does not limit users to construct 
gene set networks of only gene sets in the Gene Set Box. PAGER allows users to expand 
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the gene set networks by constructing gene set networks of upstream, downstream, and 
co-membership gene sets. 
In addition to gene set networks, after users entered searching terms, PAGER returns both 
related genes and gene sets. The chart in Figure 3.10, which is a larger version of blue 
rectangle area in Figure 3.7, explained features of PAGER which related to gene networks. 
For instance, after searching, users can add genes into Gene Box, which is an area for user 
to save their genes, and build gene regulation and gene interaction networks of the genes 
in their Gene Box. In addition, users can construct gene set networks of either 
downstream, upstream, and sibling genes of a particular gene. 
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Figure 3.9 PAGER gene set network features 
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Figure 3.10 PAGER gene network features
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3.2.4 PAGER Use cases 
This section described different ways of using PAGER to study systems biology. Five use 
cases, including searching gene and gene sets by terms, searching gene sets by a list of 
genes, constructing gene set networks, generating expanded gene set networks, and 
viewing gene networks of genes inside a gene set were presented together with 
screenshots. 
3.2.4.1 Searching Genes and Gene Sets by Terms 
Users go to PAGER home page (Figure 3.11) and enter searching terms such as a disease 
name or a gene symbol. For this use case, we entered “non small cell lung” to search for 
non-small cell lung cancer related gene sets. PAGER returned a list of results (Figure 3.12). 
The list contains genes and gene sets which relate to the searching terms in different 
aspects. In this case, “non small cell lung” matched with names of 160 gene sets and 
descriptions of 720 gene sets. “non small cell lung” is not a name or a symbol of a gene, 
so PAGER returned 0 for a member of gene set line. However, if users entered “BRAF”, 
which is a gene symbol, PAGER returned 501 gene sets which contain BRAF gene (Figure 
3.13). The next step is clicking on the 160 gene sets which relate to “non small cell lung”. 
PAGER displayed a list of the 160 gene sets (Figure 3.14). The gene sets can be sorted by 
name, size, organism, or data source. We filtered only gene sets whose sizes is between 
5 and 500 and are from humans. Gene sets can be added to Gene Set Box for further 
analysis. Checkboxes in the left most column were checked if gene sets were already in 
the Gene Set Box. 
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Figure 3.11 PAGER home page 
 
Figure 3.12 PAGER results of searching by “non small cell lung” 
 
 
Figure 3.13 PAGER results of searching by “BRAF” 
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Figure 3.14 PAGER displays a list of result gene sets 
 
20 gene sets were added into the Gene Set Box. The status of Gene and Gene Set Box 
were presented on the top right of the page (Figure 3.11). We clicked in the status box to 
see all gene sets in Gene Set Box (Figure 3.15). On this page, users can view co-
membership and regulatory gene set networks of gene sets in the box, remove gene sets, 
download gene sets, and create a new gene set by combining all genes from gene sets in 
the Gene Set Box. 
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This use case showed that PAGER is useful for searching genes and gene sets related to 
terms. In case of searching for genes, the searching steps are the same as searching for 
gene sets. Users can add genes into Gene Box and create gene interaction and gene 
regulation networks. 
 
Figure 3.15 PAGER displays a list of gene sets in Gene Set Box 
 
3.2.4.2 Searching Gene Sets by a List of Genes 
On PAGER home page (Figure 3.11), users can enter a list of genes obtained from their 
experiment or other data sources in order to search for related gene sets. In this use case, 
a list of 94 non-small cell lung cancer genes were entered. PAGER displayed gene sets 
which related to the list of 94 genes and 28 gene sets were displayed after we applied 
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some filters (Figure 3.16). PAGER counted the number of shared genes and calculated a 
significant value for each gene set. Users can click on a gene set name to see more detail 
about a gene set or add gene sets into Gene Set Box as in the previous use case. Note that 
the significant value of each gene set was computed on-the-fly by using hypergeometric 
function provided by the additional PHP library. Therefore, it is possible that if the number 
of shared genes or the size of gene set is very high, the hypergeometric function cannot 
compute p-value because of number overflow.   
 
Figure 3.16 PAGER displays a list of gene sets which relate to the list of 94 genes 
 
This use case showed that PAGER is useful for searching gene sets related to a list of genes 
together with significant values. These results will be useful for constructing co-
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membership and regulatory gene set networks which are corresponding a particular list 
of genes obtained from biological experiments. 
3.2.4.3 Constructing Gene Set networks 
Users can construct co-membership and regulatory gene set networks of their selected 
gene sets. In this use case, the 28 gene sets from the previous case study were added into 
Gene Set Box. On the Gene Set Box page (Figure 3.15), co-membership and regulatory 
gene set networks were constructed and displayed by clicking “View gene set network” 
button (Figure 3.17, 3.18).  
 
Figure 3.17 PAGER displays a regulatory gene set network of 28 gene sets 
 
An instruction of using gene set network visualization was displayed on the right side. 
Users move a mouse over a gene set to see more detail about the gene set and see its 
neighbors (Figure 3.17), and move a mouse over an edge to see the detail of the edge. 
Users drag a mouse to cover gene set nodes for multiple selection. On the network page, 
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users can also add or remove gene set from Gene Set Box. Users select a gene set and 
click the link on the right hand side to see more detail about the gene set. There are two 
taps for displaying a regulatory gene set network, a directed network, and a co-
membership gene set network, an undirected network. 
 
Figure 3.18 PAGER displays a co-membership gene set network of 28 gene sets 
 
This use case showed the main contribution of PAGER, constructing gene set networks 
corresponding to searching terms or a list of genes. Co-membership and regulatory 
network were constructed from the pre-computed global gene set networks. This feature 
make PAGER different from several existing works. MetaNet [32] allows users to construct 
gene set networks base on a list of genes. However, it allows users to construct a network 
of gene sets obtained from only one data source. HPD [7] allows users to only search for 
human pathway using a list of proteins and provide a similarity matrix for the results 
pathways. PAGED [19] allows users to search for pathways and gene sets by terms or a list 
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of genes. It provides a downloadable file for co-membership gene set network of the 
results gene sets. Our PAGER provides a more flexible tool for users to construct gene set 
networks. Users search and select only gene sets in which they are interested from 
multiple data sources and view interactive gene set networks on browser. 
3.2.4.4 Generating Expanded Gene Set Networks 
When a gene set was selected by dragging a mouse cover a node, a link to see more detail 
about a gene set was displayed on the right hand side (Figure 3.18). A non small cell lung 
cancer gene set from MSigDB was selected; and Figure 3.19 showed the detail of the gene 
set. On this detail page, users click on a diagram to construct expanded networks. The 
expanded networks are networks of upstream, downstream, and co-membership gene 
sets. 
This use case showed another contribution of PAGER, constructing expanded gene set 
networks. Other existing tools did not provide a way for users to expand a gene set 
network. By expanding gene set networks, users are not limited to see only a network of 
their selected gene sets. 
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Figure 3.19 PAGER displays a detail of Non small cell lung cancer gene set 
 
3.2.4.5 Viewing Gene Networks of Genes inside a Gene Set 
In addition to the expanded gene set network, PAGER enables gene interaction and gene 
regulation network within a gene set. From Figure 3.19, users click on the central button 
in the diagram to see gene networks of a particular gene set (Figure 3.20). Typically, 
system biology tools allow users to construct either gene networks or gene set networks. 
To our knowledge, there is no tool that supports constructing both gene set networks and 
gene networks for a gene set. 
63 
 
6
3
 
 
Figure 3.20 A gene network of Non small cell lung cancer gene set 
 
This use case showed that it is useful for researchers to see both levels of system biology 
networks, gene set level and gene level. For example, users search for gene sets by a list 
of gene from their experiment, construct gene set networks of the related gene sets to 
find significant gene sets, and construct gene networks of the significant gene sets to find 
significant genes. 
3.2.4.6 Constructing Disease Specific Gene Set Networks 
This use case showed how PAGER can be used to construct disease specific gene set 
networks. In this scenario, a list of disease related genes was not required. We searched 
for non-small cell lung cancer related gene sets by using “non small cell lung”. The terms 
matched with the names of 160 gene sets.  5 human gene sets were added to Gene Set 
Box. On the Gene Set Box page, users create a new gene set by clicking on Create a new 
gene set button. PAGER displayed a list of gene and the number of gene sets which 
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contain a particular gene (Figure 3.21). AKAP12 gene has the highest frequency suggesting 
that it is an important gene among the five gene sets in Gene Set Box. On this page, when 
users click on Use all genes to search by a list of genes, PAGER automatically generate a 
list of genes and fill in the text area in PAGER home page (Figure 3.11). 
This use case showed that PAGER allows users to search for gene sets which contain a 
disease name, combine and rank the genes of the result gene sets, use a new list of 
disease related gene to search for disease related gene sets, and construct disease related 
gene set networks. This feature is different from direct constructing gene set networks 
from result gene sets because searching by a disease name returns only gene sets whose 
names contain the disease name. However, for a particular disease, some gene sets which 
relate to the disease do not contain the disease name. To our knowledge, only PAGED [19] 
provide this feature. However, it still lack of network visualization, a regulatory gene set 
network, and gene networks within a gene set. 
 
Figure 3.21 A gene network of Non small cell lung cancer gene set 
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CHAPTER 4. CONCLUSION 
To study complex biological networks, the traditional approach is based on the 
identification of interactions among internal components of gene sets. Little is known 
about relationships among higher order biological processes. Several types of the high 
level network, a gene set network, have been proposed, including co-membership, 
protein linkage, and co-enrichment gene set networks. In this study, we proposed a 
method to construct a new type of gene set network, a regulatory gene set network. A 
regulatory gene set network reveals novel relationships among gene sets together with 
directionality information. This study consists of two parts, constructing a regulatory gene 
set network and developing PAGER to allow users to construct several types of gene and 
gene set networks. 
In the first part, a regulatory gene set network and a co-membership gene set network 
were constructed for each gene set collection. We showed that a regulatory gene set 
network provides complementary information to a co-membership gene set network, 
which is commonly constructed by several studies, by presenting the low percentage of 
shared edges between the two networks. We compared degree centrality of the KEGG 
co-membership network and degree centrality of the KEGG regulatory network and found 
that the correlation is relatively high, suggesting that the gene set which is important in
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a co-membership gene set network is likely to be important in a regulatory gene set 
network. However, the different topology of the networks suggests that the two networks 
can be used to explain different phenomenon in biological systems. To validate both the 
KEGG co-membership network and the KEGG regulatory network constructed in this 
study, the two networks were compared with KEGG co-enrichment network obtained 
from Jignesh, et al. [32]. We found that the number of shared edges between the KEGG co-
enrichment network and the KEGG regulatory network and the number of shared edges 
between the KEGG co-enrichment network and the KEGG co-membership network are 
significantly high. These results are corresponding to the facts that a pair of gene sets 
which have a strong regulatory relationship and share a significant number of genes 
should be connected with co-enrichment. Finally, a regulatory gene set network specific 
to Alzheimer's disease was constructed. We showed that the network is useful for 
understanding the underlying mechanism of the disease. 
After we found that a regulatory gene set network is useful for systems biology study, 
PAGER was implemented. PAGER is an online platform for searching gene sets and 
constructing gene set networks to reveal insights into biological systems. PAGER contains 
166,489 gene sets integrated from 10 different gene set data sources. The total number 
of unique genes is 44,188. Gene regulations and gene interactions were collected from 4 
different data sources. The total number of unique gene regulations is 651,586 and the 
total number of unique gene interactions is 650,160. Human gene regulations were 
collected and filtered for constructing a regulatory gene set network. PAGER provides pre-
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computed global regulatory and global co-membership gene set networks allowing users 
to construct networks of their gene sets. PAGER has several unique features which have 
not been provided before by other existing tools. First, PAGER not only allows users to 
construct two types of gene set networks, PAGER enables users to construct a gene 
interaction network and a gene regulation network of genes inside a gene set. Second, 
PAGER allows users to construct three types of expanded gene set networks including 
networks of upstream, downstream, and co-membership gene sets. Constructing 
expanded gene set networks enables users to find more important gene sets related to 
their study. Third, because PAGER offers gene networks, users can also construct 
expanded gene networks from a gene including networks of upstream, downstream, and 
sibling genes. Finally, PAGER provides an interactive visualization tool for users to study 
gene and gene set networks and offers spaces, Gene Box and Gene Set Box, for users to 
store their genes and gene sets. 
In conclusion, we provided a method to construct a regulatory gene set network and 
methods to construct both global and disease specific gene set networks, which enable 
future systems biology and translational bioinformatics research. The underlying gene 
regulation data were collected from high quality and high coverage data sources, so 
directed edges in a regulatory gene set network do not tend to depend on the number 
and the quality of experimental data. The directionality information from a regulatory 
gene set network enables finding of source gene sets and sink gene sets which might be 
important for drug discovery or drug repositioning. PAGER offers several tools to enable 
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systems biology and further analysis of gene lists obtained from high throughput 
experiments. Users can use PAGER to search for genes and gene sets, construct co-
membership gene set networks and regulatory gene set networks, and construct gene 
interaction networks and gene regulation networks in order to understand the underlying 
processes of disease or drugs. 
However, in this study, we have not yet considered tissue specific or disease specific gene 
regulations, so the disease specific network might not have high accuracy of presenting 
the high level relationship among gene sets. Therefore, our framework can be improved 
by collecting higher resolution data, such as tissue specific and disease specific gene 
regulation data and gene set data. In addition, experimental gene expression data can be 
used to obtain gene set ranking and can be further applied to add more information to 
the gene set network. For the current version of PAGER, the sizes of gene and gene set 
networks are limited. PAGER cannot display a network which has more than 100 nodes, 
due to browser memory constraint. Our future plans are to integrate tissue specific 
information and to integrate internal genes or proteins interactions inside pathways in 
order to support future systems biology study. However, with this first version of PAGER, 
we enabled researchers to construct several types of networks, especially a regulatory 
gene set network, to reveal novel insights into complex biological systems. 
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